Studies that Show Lipitor Causing Diabetes in Women
Studies have confirmed reports of Lipitor causing diabetes in women. Lipitor, manufactured by Pfizer Pharmaceuticals, was intended to treat high cholesterol levels. While it is very effective in lowering cholesterol levels, studies have shown that it significantly increases the risk of developing type II diabetes in post-menopausal women. Several lawsuits have been filed against Pfizer’s Lipitor drug with success.
The Abbott Law Firm is interested in representing you if you developed type II diabetes while you were taking name brand Lipitor and your BMI is below 32. The reason is that diabetes is a disease associated with weight gain. Women with a BMI below 32 are not at risk of diabetes due to weight but if they have been taking Lipitor and have developed the disease, it shows that Lipitor may be responsible for the type II diabetes.
Briefing of Lipitor Causing Diabetes in Women
Lipitor is a brand name for the drug Atorvastatin. The drug belongs to a class of drugs known as statins and hypolipidemics to be precise. Following approval by the FDA in 1996, the Lipitor drug was making an annual sales figure of $13 billion.
There are several statins. Unfortunately, atovarsatin is classified as a highly potent statin. The least potent is fluvastatin. Lovastatin is found naturally in oyster mushrooms while Mevastatin occurs naturally in red yeast rice.
The drug works by preventing the creation of cholesterol by the body through blocking the release of a certain enzyme from the liver. This will in turn help the body to lower the prominence of LDL- cholesterol also known as low density lipoprotein. This is the “bad cholesterol” in the body.
Through such a working mechanism, the body becomes unable to store cholesterol, thus reducing the risk of cardiovascular illnesses such as atherosclerosis. Atherosclerosis is the accumulation of cholesterol in the blood vessels.
Studies on Lipitor and Diabetes in Women
Several studies have been done on Lipitor to establish its efficacy. While the results have been positive the drug has side effects that have been found to outweigh the benefits. Lipitor causing diabetes in women has led to skepticism in the use of the drug. Consumers worry that in the quest to manage high cholesterol levels, they introduce other long-term illnesses such as Diabetes type II to the body.
According to a report published in Circulation: Cardiovascular Quality and Outcomes, a medical journal, the benefits of statins outweigh the risks. The researchers from the Mayo Clinic also carried out a research that showed the reduction of esophageal cancer with statin use. These are the studies that have shown other advantages of statins. The other studies reflect poorly on Lipitor causing diabetes in women.
In 2004, the medical journal Circulation published a research study that showed high Lipitor doses translated into worsening glycemic control in patients. This means that blood sugar levels rose and the body could not control it adequately.
In 2010, The Lancet, a medical journal also published a research study that showed the risk of Type II diabetes in women who were on Lipitor. The study showed a comparison of women not taking Lipitor and those on the drug prescribed and how the prevalence of diabetes differed in the two groups.
In March 2011, the Journal of the American College of Cardiology also published another study that showed the prevalence of diabetes type II specifically with the use of Lipitor. Lipitor causing diabetes in women has been researched over the last decade. The results of the study confirm that indeed the drug increases the risk for developing diabetes.
Recent Studies on Lipitor Causing Diabetes in Women
On January 23 2013, the JAMA Internal Medicine, formerly the Archive of Internal Medicine published the results of a study that spanned five years from 1993 to 1998. Follow ups till 2005 with data collection followed the study. The study was carried out on 161 808 post menopausal women. Their ages were between 50 and 79 and they were spread out in 40 clinical centers in the U.S. The study’s main objective was to determine whether there was a correlation between diabetes type II and statin use.
The study concluded that women with a BMI below 30 had a higher risk of diabetes mellitus as compared to women with a BMI figure over 30. The study also showed an increased risk of type II diabetes in post-menopausal women on statin medication.
On November 8, 2012, The Lancet Journal carried a research report on studies done on the benefits of statins which found out that the benefits outweighed the risk of developing diabetes. However, AstraZeneca, the manufacturer of the statin Crestor, funded this study. The study showed significantly reduced mortality rated in patients on statins. It also showed that there was no increased risk of developing diabetes in patients without serious risk factors for the development of diabetes.
Another study published in the British Medical Journal stated that there was an increased risk of diabetes especially with higher Lipitor doses taken over a period of time. The study also linked diabetes to highly potent statins stating that there were high chances of developing the disease with prolonged intake of statin drugs.
The most recent study so far was published on 9th July 2013 in The Lancet Journal. The study shows that although there is a strong correlation of Lipitor to diabetes type II, statins lower cholesterol and decrease overall body inflammation.
What Plaintiffs Say about Lipitor Causing Diabetes in Women
Plaintiffs see this as an act of sabotage. The pharmaceutical company chooses to put its interests first before the health of consumers which has led to the development of diabetes type II in most of them. Several plaintiffs are suing Pfizer for this and ask that future drug manufacturer be backed with adequate studies that show clearly what a patient should expect. The pros and cons should not be concealed but rather exposed to enable the consumers or patients to make an informed choice.
If you feel that you may be eligible for compensation, contact us today. We are representing women with a BMI of 32 and below in suing for compensation in court. BMI means body mass index. BMI is used to check body weight and determine whether a patient is overweight, normal weight/healthy or underweight. A BMI of 32 and also classifies a patient as a low risk patient of diabetes that is associated with weight gain.
Contact The Abbott Law Group today at 1-800-499-6652 or fill out our online form. Leave a name and contact number and expect a call within 24 hours from our law firm. We want the chance to fight for the compensation you deserve to help cover your medical bills. Lipitor causing diabetes in women is not new and plaintiffs may win cases against Pfizer for the type II diabetes side effect.